DK1565445T3 - Fremgangsmåde til fremstilling af imidazolylforbindelser - Google Patents

Fremgangsmåde til fremstilling af imidazolylforbindelser

Info

Publication number
DK1565445T3
DK1565445T3 DK03811396T DK03811396T DK1565445T3 DK 1565445 T3 DK1565445 T3 DK 1565445T3 DK 03811396 T DK03811396 T DK 03811396T DK 03811396 T DK03811396 T DK 03811396T DK 1565445 T3 DK1565445 T3 DK 1565445T3
Authority
DK
Denmark
Prior art keywords
preparation
imidazolyl compounds
imidazolyl
compounds
Prior art date
Application number
DK03811396T
Other languages
Danish (da)
English (en)
Inventor
Jan-Maarten Verbeek
Der Meij Paulus F C Van
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Application granted granted Critical
Publication of DK1565445T3 publication Critical patent/DK1565445T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK03811396T 2002-11-18 2003-11-17 Fremgangsmåde til fremstilling af imidazolylforbindelser DK1565445T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079838 2002-11-18
PCT/EP2003/050841 WO2004046116A1 (en) 2002-11-18 2003-11-17 Novel process for the preparation of imidazolyl compounds

Publications (1)

Publication Number Publication Date
DK1565445T3 true DK1565445T3 (da) 2007-01-29

Family

ID=32319633

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03811396T DK1565445T3 (da) 2002-11-18 2003-11-17 Fremgangsmåde til fremstilling af imidazolylforbindelser

Country Status (25)

Country Link
EP (1) EP1565445B1 (de)
JP (1) JP4611026B2 (de)
KR (1) KR20050075026A (de)
CN (1) CN100349873C (de)
AR (1) AR041955A1 (de)
AT (1) ATE340783T1 (de)
AU (1) AU2003296762B2 (de)
BR (1) BR0316308A (de)
CA (1) CA2504614C (de)
DE (1) DE60308720T2 (de)
DK (1) DK1565445T3 (de)
ES (1) ES2273088T3 (de)
HK (1) HK1081188A1 (de)
HR (1) HRP20050376A2 (de)
IL (1) IL168258A (de)
MX (1) MXPA05005261A (de)
NO (1) NO330342B1 (de)
PL (1) PL376743A1 (de)
PT (1) PT1565445E (de)
RU (1) RU2314296C2 (de)
SA (1) SA03240414B1 (de)
SI (1) SI1565445T1 (de)
UA (1) UA79655C2 (de)
WO (1) WO2004046116A1 (de)
ZA (1) ZA200503425B (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.

Also Published As

Publication number Publication date
AR041955A1 (es) 2005-06-01
RU2005119155A (ru) 2006-01-20
CN1714082A (zh) 2005-12-28
HK1081188A1 (en) 2006-05-12
SA03240414B1 (ar) 2006-12-05
EP1565445B1 (de) 2006-09-27
UA79655C2 (en) 2007-07-10
KR20050075026A (ko) 2005-07-19
HRP20050376A2 (en) 2006-02-28
DE60308720D1 (de) 2006-11-09
DE60308720T2 (de) 2007-01-11
JP2006512322A (ja) 2006-04-13
NO330342B1 (no) 2011-03-28
PL376743A1 (pl) 2006-01-09
ZA200503425B (en) 2007-02-28
CA2504614C (en) 2010-09-28
NO20052950D0 (no) 2005-06-16
NO20052950L (no) 2005-08-15
RU2314296C2 (ru) 2008-01-10
JP4611026B2 (ja) 2011-01-12
AU2003296762B2 (en) 2010-03-18
BR0316308A (pt) 2005-09-27
CA2504614A1 (en) 2004-06-03
AU2003296762A1 (en) 2004-06-15
PT1565445E (pt) 2007-01-31
WO2004046116A1 (en) 2004-06-03
IL168258A (en) 2010-05-31
MXPA05005261A (es) 2005-07-25
EP1565445A1 (de) 2005-08-24
ATE340783T1 (de) 2006-10-15
CN100349873C (zh) 2007-11-21
ES2273088T3 (es) 2007-05-01
SI1565445T1 (sl) 2007-02-28

Similar Documents

Publication Publication Date Title
DK1611108T3 (da) Fremgangsmåde til fremstilling af telmisartan
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1651622T3 (da) Fremgangsmåde til fremstilling af 2-(quinoxalin-5-ylsulfonylamino)-benzamidforbindelser
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1578731T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
DK1373255T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1572613T3 (da) Fremgangsmåde til fremstilling af benzophenoner
DK1794152T3 (da) Fremgangsmåde til fremstilling af enantiomeriske imidazol-forbindelser
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1503995T3 (da) Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer
DK1692137T3 (da) Fremgangsmåde til fremstilling af tubulinininhibitorer
DK1519936T3 (da) Fremgangsmåde til fremstilling af nevirapin
NO20052396D0 (no) Fremgangsmate for fremstilling av spirolactonforbindelser